Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Idera Pharmaceutical (IDRA)

2.17 -0.05 (-2.25%)

11-22 16:00

Open:

2.24

Pre. Close:

2.22

High:

2.28

Low:

2.16

Volume:

1,219,961

Market Cap:

397M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.3 - 2.37

2.37 - 2.45

Low:

1.99 - 2.05

2.05 - 2.12

Close:

2.06 - 2.16

2.16 - 2.29

Technical analysis  (as of: 2017-11-22 5:02:16 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.81     One year: 3.29

Support:

Support1: 1.74    Support2: 1.32

Resistance:

Resistance1: 2.41    Resistance2: 2.81

Pivot:

1.99

Moving Averages:

MA(5): 2.16     MA(20): 1.88

MA(100): 2.01     MA(250): 1.89

MACD:

MACD(12,26): 0.02     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 88.43     %D(3): 91.45

RSI:

RSI(14): 55.31

52-Week:

High: 2.87  Low: 1.3  Change(%): 18.6

Average Vol(K):

3-Month: 242920  10-Days 267682

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
IDRA has closed below upper band by 23.9%. Bollinger Bands are 27.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 09 Nov 2017 18:11:15 GMT
Why Idera Pharmaceuticals Inc. Jumped Higher Today

Wed, 22 Nov 2017 13:07:30 GMT
Why to Keeping Eye on Idera Pharmaceuticals, Inc. (IDRA), Ally Financial Inc ...

Wed, 15 Nov 2017 22:30:06 GMT
Idera Pharmaceuticals Inc. (IDRA) Plunges 5.26% on November 15

Thu, 26 Oct 2017 16:18:45 GMT
Here's Why Idera Pharmaceuticals Plunged as Much as 35% Today

Tue, 24 Oct 2017 19:52:30 GMT
Idera Pharmaceuticals Provides Corporate Governance Update

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

183.01

Shares Float (M)

137.53

% Held by Insiders

12.88

% Held by Institutions

25.81

Shares Short (K)

12210

Shares Short Prior Month (K)

12130

Stock Financials

EPS

-0.340

EPS Est. Current Year

-0.480

EPS Est. Next Year

-0.500

EPS Est. Next Quarter

-0.120

Forward EPS

-0.420

Book Value (p.s.)

0.500

PEG Ratio

Profit Margin

Operating Margin

-268.64

Return on Assets (ttm)

-35.6

Return on Equity (ttm)

-71.5

Qtrly Rev. Growth

-37.9

Gross Profit (p.s.)

0.089

Sales Per Share

EBITDA (p.s.)

-0.233

Qtrly Earnings Growth

Operating Cash Flow (M)

-37.56

Levered Free Cash Flow (M)

-16.51

FoxReading.com

Valuation

P/E

-6.38

P/E Growth Ratio

-0.02

P/BV

4.34

P/S

3610288384.00

P/CF

-10.57

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.